April 2012 Drug Information Update - Pharmacy Benefits ...
April 2012 Drug Information Update - Pharmacy Benefits ...
April 2012 Drug Information Update - Pharmacy Benefits ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
PRODUCT (Biologics Class II)<br />
Hepatitis C Virus Encoded Antigen (Recombinant c200) CHIRON HCV c200 Antigen; Stock<br />
Number: 4392-801, 4392-802, 4392-805 (4392-805 only item distributed for this lot); (The<br />
product is for Further Manufacturing Use/Recombinant). Recall # B-0673-12<br />
CODE<br />
Lot # 127129<br />
RECALLING FIRM/MANUFACTURER<br />
Novartis Vaccine and Diagnostics, Inc., Emeryville, CA, by telephone, e-mail, and letter on<br />
December 12, 2011. Firm initiated recall is complete.<br />
REASON<br />
Hepatitis C Virus Encoded Antigen (For Further Manufacturing Use, formulated with a reduced<br />
concentration of Dithiothreitol (DTT) in the formulation buffer, was distributed.<br />
Current <strong>Drug</strong> Shortages<br />
Caffeine and Ergotamine Tartrate<br />
February 24, <strong>2012</strong><br />
Products Affected - Description<br />
Cafergot tablets, Sandoz<br />
100 mg caffeine/ 1 mg ergotamine tartrate, 100 count bottle (NDC 00781-5405-01)<br />
Reason for the Shortage<br />
• Sandoz states the shortage is due to a change in the raw material plant location.<br />
• Sandoz is the only manufacturer of caffeine and ergotamine tablets.<br />
• Cypress discontinued their caffeine and ergotamine tablets in February, 2011 and West-Ward<br />
discontinued their product in <strong>April</strong>, 2010.<br />
Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=880<br />
Source: www.ashp.org<br />
Liotrix Tablets<br />
February 27, <strong>2012</strong><br />
Products Affected - Description<br />
Thyrolar tablets, Forest Laboratories<br />
12.5/3.1, 100 count (NDC 00456-0040-01)<br />
25/6.25, 100 count (NDC 00456-0045-01)<br />
50/12.5, 100 count (NDC 00456-0050-01)<br />
100/25, 100 count (NDC 00456-0055-01)<br />
150/37.5, 100 count (NDC 00456-0060-01)<br />
Reason for the Shortage<br />
• Thyrolar tablets from Forest Laboratories are on back order due to manufacturing changes.<br />
Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=24<br />
Source: www.ashp.org<br />
Nystatin Vaginal Tablets<br />
February 29, <strong>2012</strong><br />
Products Affected - Description<br />
Nystatin Vaginal Tablets, Teva<br />
100,000 unit tablets, 15 count (NDC 51285-0534-22)<br />
34